10-year outcome of a randomized trial comparing neoadjuvant chemoradiotherapy and surgery with surgery alone for esophageal cancer (CROSS trial)
Ben M. Eyck(Erasmus MC Cancer Institute), Ate van der Gaast(Erasmus MC), Mark I. van Berge Henegouwen(University of Namur), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Cornelis J.A. Punt(Utrecht University), Miguel A. Cuesta(Hospital General Universitario de Albacete), Caroline van Rij(Erasmus MC), John Th. M. Plukker(University Medical Center Groningen), Maarten C.C.M. Hulshof(Academic Medical Center), Henk M.W. Verheul(Erasmus MC Cancer Institute), Ewout W. Steyerberg(Erasmus MC), Ernst Spillenaar Bilgen(Rijnstate Hospital), Fiebo ten Kate(Erasmus MC), G.J. Creemers(Radboud University Nijmegen), Jan van Lanschot(Erasmus MC Cancer Institute), Maurice van der Sangen(Radboud University Nijmegen), Geke A.P. Hospers(University Medical Center Groningen)
Cited by 2
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Towards better clinical prediction models: seven steps for development and an ABCD for validation
|European Heart Journal|2014|1.9k
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
|PLoS Medicine|2013|1.5k